Eisai
4523.T
#2184
Rank
S$10.97 B
Marketcap
S$38.90
Share price
0.11%
Change (1 day)
-0.84%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$4.89 Billion

According to Eisai's latest financial reports the company's total liabilities are S$4.89 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31S$4.66 B5.9%
2024-03-31S$4.40 B0.2%
2023-03-31S$4.39 B-15.51%
2022-03-31S$5.20 B18.33%
2021-03-31S$4.39 B-7.51%
2020-03-31S$4.75 B-7.12%
2019-03-31S$5.11 B-4.58%
2018-03-31S$5.36 B-0.18%
2017-03-31S$5.37 B12.89%
2016-03-31S$4.76 B-7.9%
2015-03-31S$5.16 B-4.6%
2014-03-31S$5.41 B-20.22%
2013-03-31S$6.79 B-22.95%
2012-03-31S$8.81 B-8.31%
2011-03-31S$9.61 B-5.08%
2010-03-31S$10.12 B-8.02%
2009-03-31S$11.01 B21.85%
2008-03-31S$9.03 B205.72%
2007-03-31S$2.95 B-6.17%
2006-03-31S$3.14 B0.68%
2005-03-31S$3.12 B-1.04%
2004-03-31S$3.16 B3.65%
2003-03-31S$3.05 B18.18%
2002-03-31S$2.58 B-11.54%
2001-03-31S$2.91 B